Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
29.05M
Gross Profit
-29.05M
Operating Income
-28.97M
Interest Income
n/a
Pretax Income
-28.97M
Net Income
-27.47M
Selling & General & Admin
11.37M
Research & Development
17.68M
Other Expenses
n/a
Operating Expenses
29.05M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
29.05M
Income Tax Expense
-1.51M
Shares Outstanding (Basic)
15.44M
Shares Outstanding (Diluted)
15.44M
EPS (Basic)
-1.78
EPS (Diluted)
-1.78
EBITDA
-28.92M
EBIT
n/a
Depreciation & Amortization
55K